401 related articles for article (PubMed ID: 28056845)
1. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
2. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
[TBL] [Abstract][Full Text] [Related]
5. Usage of Plasma Presepsin, C-Reactive Protein, Procalcitonin and Proadrenomedullin to Predict Bacteremia in Febril Neutropenia of Pediatric Hematological Malignancy Patients.
Arıkan K; Karadag-Oncel E; Aytac S; Cetin M; Cengiz AB; Gümrük F; Kara A; Ceyhan M
Lab Med; 2021 Sep; 52(5):477-484. PubMed ID: 33851202
[TBL] [Abstract][Full Text] [Related]
6. The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
Cerasi S; Leardini D; Lisanti N; Belotti T; Pierantoni L; Zama D; Lanari M; Prete A; Masetti R
Sci Rep; 2023 Apr; 13(1):6464. PubMed ID: 37081067
[TBL] [Abstract][Full Text] [Related]
7. Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia.
Agnello L; Bivona G; Parisi E; Lucido GD; Iacona A; Ciaccio AM; Giglio RV; Ziino O; Ciaccio M
Lab Med; 2020 Nov; 51(6):585-591. PubMed ID: 32221546
[TBL] [Abstract][Full Text] [Related]
8. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients.
Plesko M; Suvada J; Makohusova M; Waczulikova I; Behulova D; Vasilenkova A; Vargova M; Stecova A; Kaiserova E; Kolenova A
Neoplasma; 2016; 63(5):752-60. PubMed ID: 27468879
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
[TBL] [Abstract][Full Text] [Related]
10. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
[TBL] [Abstract][Full Text] [Related]
11. Combination of sepsis biomarkers may indicate an invasive fungal infection in haematological patients.
Stoma I; Karpov I; Uss A; Krivenko S; Iskrov I; Milanovich N; Vlasenkova S; Lendina I; Belyavskaya K; Cherniak V
Biomarkers; 2019 Jun; 24(4):401-406. PubMed ID: 30907674
[No Abstract] [Full Text] [Related]
12. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
14. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.
Ozdemir AA; Elgormus Y
Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177
[No Abstract] [Full Text] [Related]
17. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
[TBL] [Abstract][Full Text] [Related]
19. The Physiological Variation in Plasma Presepsin Levels During the Early Neonatal Period.
Ishii M; Hoshina T; Ichikawa S; Shimizu D; Araki S; Kinjo T; Shibata E; Hachisuga T; Kusuhara K
Tohoku J Exp Med; 2018 Nov; 246(3):199-203. PubMed ID: 30487373
[TBL] [Abstract][Full Text] [Related]
20. Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.
Nanno S; Koh H; Katayama T; Hashiba M; Sato A; Makuuchi Y; Nagasaki J; Kuno M; Yoshimura T; Okamura H; Nishimoto M; Hirose A; Nakamae M; Nakane T; Hino M; Nakamae H
Intern Med; 2016; 55(16):2173-84. PubMed ID: 27522992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
